WFDC2 and interstitial lung disease: Approximately 60% of RA patients are also diagnosed with ILD, and both two studies reported the increased levels of serum WFDC2 in RA-ILD patients when compared to the RA-non-ILD patients and healthy controls (Liang et al., 2021; Lin et al., 2022).